Document is current
Any future updates will be listed below
-
Authors
Craig, H. C. https://orcid.org/0000-0002-7288-5245
Alsaeed, D.
Al Ozairi, E. https://orcid.org/0000-0001-5006-4369
Norris, S.
Holian, J.
Kennedy, C. https://orcid.org/0000-0002-2577-0242
Heneghan, H.
McGillicuddy, D.
Farrell, E.
Hollmann, E.
Al-Najim, W.
le Roux, C. W. https://orcid.org/0000-0001-5521-5445
- License Information
-
More Information
Article History
Received: 21 August 2024
Revised: 5 March 2025
Accepted: 9 April 2025
First Online: 24 April 2025
Competing interests
: HCC, Funding of PhD tuition fees from the Stratification of Obesity Phenotypes to Optimize Future Obesity Therapy (SOPHIA) project (). DA—no conflict of interest. EA – no conflict of interest. SN – no conflict of interest, JH – no conflict of interest. CK – no conflict of interest. HH – no conflict of interest. WA-N – no conflict of interest. DM – no conflict of interest, EF – no conflict of interest, EH – no conflict of interest. CWlR: Consulting fees/Honoraria/Support for meetings: Novo Nordisk, Eli Lilly, Johnson & Johnson, Boehringer Ingelheim, GI Dynamics, Herbalife. Leadership/fiduciary role in Board: Irish Society for Nutrition and Metabolism (unpaid).
: Ethical approval was obtained from the Human Research Ethics Committee (LS-21-58-LeRoux) (HREC), University College Dublin, Ireland, August 6th, 2021, and conducted according to the Declaration of Helsinki. Informed consent was obtained from all individual participants included in the study.
: Patients signed informed consent regarding publishing their data and photographs.
